Early activated Th-1 type and dominantly diverse natural killer T (CD3 +CD161 +Vα24 -) cells in bone marrow among visceral leishmaniasis patients

International Journal for Parasitology

Volumn 41, Issue 10, 2011, Pages 1069-1077

  Rai, Ambak Kumar ^a   Thakur, Chandreshwar Prasad ^b   Seth, Tulika ^a   Mitra, Dipendra Kumar ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b Balaji Utthan Sansthan   (India)

Author keywords

Diverse TCR; NKT cells; Visceral leishmaniasis

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; CD161 ANTIGEN; CD3 ANTIGEN;

ANTIGEN; BONE; CELL ORGANELLE; LEISHMANIASIS; LIGAND; LIPID; PARASITOLOGY; PATHOLOGY; PHENOTYPE;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE MARROW; CD3+ T LYMPHOCYTE; CELL ACTIVATION; CELL MIGRATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LEISHMANIA DONOVANI; MALE; NATURAL KILLER T CELL; NONHUMAN; PHENOTYPE; PRESCHOOL CHILD; SCHOOL CHILD; TH1 CELL; VISCERAL LEISHMANIASIS;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD3; BONE MARROW; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; MALE; MIDDLE AGED; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY B; RECEPTORS, ANTIGEN, T-CELL; TH1 CELLS; YOUNG ADULT;

LEISHMANIA DONOVANI;

EID: 79961167543     PISSN: 00207519     EISSN: 18790135     Source Type: Journal    
DOI: 10.1016/j.ijpara.2011.05.010     Document Type: Article

References (29)

1. Amprey J.L., Im J.S., Turco S.J., Murray H.W., Illarionov P.A., Besra G.S., Porcelli S.A., Späth G.F. A subset of liver NK T cells is activated during Leishmania donovani infection by CD1d-bound lipophosphoglycan. J. Exp. Med. 2004, 200:895-904.
2. Bendelac A., Savage P.B., Teyton L. The biology of NKT cells. Annu. Rev. Immunol. 2007, 25:297-336.
3. Benlagha K., Kyin T., Beavis A., Teyton L., Bendelac A. A thymic precursor to the NK T cell lineage. Science 2002, 296:553-555.
4. Chawla M., Vishwakarma R.A. Alkylacylglycerolipid domain of GPI molecules of Leishmania is responsible for inhibition of PKC mediated cfos expression. J. Lipid Res. 2003, 44:594-600.
5. Chen H., Paul W.E. Cultured NK1.1+ CD4+ T cells produce large amounts of IL-4 and IFN-gamma upon activation by anti-CD3 or CD1. J. Immunol. 1997, 159:2240-2249.
6. Chen X., Wang X., Besra G.S., Gumperz J.E. Modulation of CD1d-restricted NKT cell responses by CD4. J. Leukoc. Biol. 2007, 82:1455-1465.
7. Chiu Y.H., Jayawardena J., Weiss A., Lee D., Park S.H., Dautry-Varsat A., Bendelac A. Distinct subsets of CD1drestricted T cells recognize self-antigens loaded in different cellular compartments. J. Exp. Med. 1999, 189:103-110.
8. Coppieters K., Van Beneden K., Jacques P., Dewint P., Vervloet A., Vander Cruyssen B., Van Calenbergh S., Chen G., Franck R.W., Verbruggen G., Deforce D., Matthys P., Tsuji M., Rottiers P., Elewaut D.A. Single early activation of invariant NKT cells confers long-term protection against collagen-induced arthritis in a ligand-specific manner. J. Immunol. 2007, 179:2300-2309.
9. Eberl G., Lees R., Smiley S.T., Taniguchi M., Grusby M.J., MacDonald H.R. Tissue specific segregation of CD1d-dependent and CD1d-independent NKT cells. J. Immunol. 1999, 162:6410-6419.
10. Esteban L.M., Tsoutsman T., Jordan M.A., Roach D., Poulton L.D., Brooks A., Naidenko O.V., Sidobre S., Godfrey D.I., Baxter A.G. Genetic control of NKT cell numbers maps to major diabetes and lupus loci. J. Immunol. 2003, 171:2873-2878.
11. Evanko S.P., Tammi I.M.I., Tammi R.H., Wight T.N. Hyaluronan-dependent pericellular matrix. Adv. Drug Deliv. Rev. 2007, 59:1351-1365.
12. Giorda R., Rudert W.A., Vavassori C., Chambers W.H., Hiserodt J.C., Trucco M. NKR-P1, a signal transduction molecule on natural killer cells. Science 1990, 249:1298-1300.
13. Godfrey D.I., MacDonald H.R., Kronenberg M., Smyth M.J., Van Kaer L. NKT cells: what's in a name?. Nat. Rev. Immunol. 2004, 4:231-237.
14. Godfrey D.I., Stankovic S., Baxter A.G. Raising the NKT cell family. Nat. Immunol. 2010, 11:197-206.
15. Hayakawa Y., Takeda K., Yagita H., Van Kaer L., Saiki I., Okumura K. Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways. J. Immunol. 2001, 166:6012-6018.
16. Ishii T., Ohnuma K., Murakami A., Takasawa N., Kobayashi S., Dang N.H., Schlossman S.F., Morimoto C. CD26-mediated signaling for T cell activation occurs in lipid rafts through its association with CD45RO. Proc. Natl. Acad. Sci. USA 2001, 98:12138-12143.
17. Johnston B., Kim C.H., Soler D., Emoto M., Butcher E.C. Differential chemokine responses and homing patterns of murine TCR alpha beta NKT cell subsets. J. Immunol. 2003, 171:2960-2969.
18. Jordan M.A., Fletcher J., Baxter A.G. Genetic control of NKT cell numbers. Immunol. Cell Biol. 2004, 82:276-284.
19. Joshi B., Khedouci S., Dagur P.K., Hichami A., Sengupta U., Khan N.A. On cell signalling mechanism of Mycobaterium leprae soluble antigen (MLSA) in Jurkat T cells. Mol. Cell. Biochem. 2006, 287:157-164.
20. Kim C.H., Rott L., Kunkel E.J., Genovese M.C., Andrew D.P., Wu L., Butcher E.C. Rules of chemokine receptor association with T cell polarization in vivo. J. Clin. Invest. 2001, 108:1331-1339.
21. Kronenberg M. Toward an understanding of NKT cell biology: progress and paradoxes. Annu. Rev. Immunol. 2005, 26:877-900.
22. Mesci A., Ljutic B., Makrigiannis A.P., Carlyle J.R. NKR-P1 Biology: from prototype to missing self. Immunol. Res. 2006, 35(1-2):13-26.
23. Osada T., Morse M.A., Lyerly H.K., Clay T.M. Ex vivo expanded human CD4+ regulatory NKT cells suppress expansion of tumor antigen-specific CTLs. Int. Immunol. 2005, 17:1143-1155.
24. Rocha-Campos A.C., Melki R., Zhu R., Deruytter N., Damotte D., Dy M., Herbelin A., Garchon H.J. Genetic and functional analysis of the Nkt1 locus using congenic NOD mice: improved Vα14-NKT cell performance but failure to protect against type 1 diabetes. Diabetes 2006, 55:1163-1170.
25. Sharma P.K., Saha P.K., Singh A., Sharma S.K., Ghosh B., Mitra D.K. FoxP3+ regulatory T cells suppress effector T-cell function at pathologic site in miliary tuberculosis. Am. J. Respir. Crit. Care Med. 2009, 179:1061-1070.
26. Stanley, A.C., Zhou, Y., Amante, F.H., Randall, L.M., Haque, A., Pellicci, D.G., Hill, G.R., Smyth, M.J., Godfrey, D.I., Engwerda, C.R., 2008. Activation of invariant NKT cells exacerbates experimental visceral leishmaniasis. PLoS Pathog. 4, e1000028.
27. Thakur C.P., Mitra D.K., Narayan S. Skewing of cytokine profiles towards T helper cell type 2 response in visceral leishmaniasis patients unresponsive to sodium antimony gluconate. Trans. R. Soc. Trop. Med. Hyg. 2003, 97:409-412.
28. Thomas S.Y., Hou R., Boyson J.E., Means T.K., Hess C., Olson D.P., Strominger J.L., Brenner M.B., Gumperz J.E., Wilson S.B., Luster A.D. CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells. J. Immunol. 2003, 171:2571-2580.
29. Wiethe C., Debus A., Moh M., Steinkasserer A., Lutz M., Gessner A. Dendritic cell differentiation state and their interaction with NKT cells determine Th1/Th2 differentiation in the murine model of Leishmania major infection. J. Immunol. 2008, 180:4371-4381.